These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 6097272

  • 1. Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers.
    Witte PU, Metzger H, Eckert HG, Irmisch R.
    Arzneimittelforschung; 1984; 34(10B):1448-51. PubMed ID: 6097272
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
    Schölkens BA, Becker RH, Kaiser J.
    Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268
    [Abstract] [Full Text] [Related]

  • 3. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats.
    Unger T, Fleck T, Ganten D, Lang RE, Rettig F.
    Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.
    Bünning P.
    Arzneimittelforschung; 1984; 34(10B):1406-10. PubMed ID: 6097266
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis of a highly active angiotensin converting enzyme inhibitor: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
    Teetz V, Geiger R, Henning R, Urbach H.
    Arzneimittelforschung; 1984; 34(10B):1399-401. PubMed ID: 6097264
    [Abstract] [Full Text] [Related]

  • 8. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor.
    Metzger H, Maier R, Sitter C, Stern HO.
    Arzneimittelforschung; 1984; 34(10B):1402-6. PubMed ID: 6097265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers.
    Bussien JP, Nussberger J, Porchet M, Waeber B, Brunner HR, Perisic M, Tansey MJ, Bomm M, Hajdu P.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):63-9. PubMed ID: 2987705
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat.
    Caspritz G, Alpermann HG, Schleyerbach R.
    Arzneimittelforschung; 1986 Nov; 36(11):1605-8. PubMed ID: 3028436
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute, subchronic and chronic toxicity of the new angiotensin converting enzyme inhibitor ramipril.
    Donaubauer HH, Mayer D.
    Arzneimittelforschung; 1988 Jan; 38(1):14-20. PubMed ID: 2966628
    [Abstract] [Full Text] [Related]

  • 17. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
    Böhm RO, van Baak MA, Rahn KH.
    Eur J Clin Pharmacol; 1986 Jan; 30(5):541-7. PubMed ID: 3019702
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.